NCT05624099 2023-10-19Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.Fujian Cancer HospitalPhase 2 Recruiting75 enrolled
NCT03187314 2020-08-17Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal CancerHangzhou Cancer HospitalPhase 2 Completed25 enrolled